Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Tom Han Jin
Introduction
Tom Han Jin is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of viral compositions, particularly in the development of stable, spray-dried immunogenic formulations. His work is crucial for advancing vaccination technologies.
Latest Patents
Tom Han Jin holds a patent for a method involving stable, spray-dried immunogenic viral compositions. This patent focuses on genetically engineered, replication-deficient viruses, such as adenoviruses and poxviruses, which encode antigens for diseases like tuberculosis, malaria, and HIV. The innovative aspect of his patent lies in the use of a mannitol-cyclodextrin-trehalose-dextran (MCTD) formulation that maintains the viability of these viruses during storage, even in humid conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Tom has worked with organizations dedicated to improving global health. Notably, he has been associated with the Aeras Global TB Vaccine Foundation and Aeras, where he contributed to the development of vaccines aimed at combating infectious diseases.
Collaborations
Tom has collaborated with several professionals in his field, including Eric I-Fu Tsao, enhancing the impact of his research and innovations.
Conclusion
Tom Han Jin's work exemplifies the importance of innovation in the field of immunology and vaccine development. His contributions are vital for future advancements in public health and disease prevention.